##gff-version 3
##sequence-region P04049 1 648
P04049	UniProtKB	Chain	1	648	.	.	.	ID=PRO_0000086596;Note=RAF proto-oncogene serine/threonine-protein kinase	
P04049	UniProtKB	Domain	56	131	.	.	.	Note=RBD;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00262	
P04049	UniProtKB	Domain	349	609	.	.	.	Note=Protein kinase;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
P04049	UniProtKB	Zinc finger	138	184	.	.	.	Note=Phorbol-ester/DAG-type;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00226	
P04049	UniProtKB	Nucleotide binding	355	363	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
P04049	UniProtKB	Region	331	349	.	.	.	Note=Interaction with PEBP1/RKIP	
P04049	UniProtKB	Active site	468	468	.	.	.	Note=Proton acceptor	
P04049	UniProtKB	Metal binding	139	139	.	.	.	Note=Zinc 1	
P04049	UniProtKB	Metal binding	152	152	.	.	.	Note=Zinc 2	
P04049	UniProtKB	Metal binding	155	155	.	.	.	Note=Zinc 2	
P04049	UniProtKB	Metal binding	165	165	.	.	.	Note=Zinc 1	
P04049	UniProtKB	Metal binding	168	168	.	.	.	Note=Zinc 1	
P04049	UniProtKB	Metal binding	173	173	.	.	.	Note=Zinc 2	
P04049	UniProtKB	Metal binding	176	176	.	.	.	Note=Zinc 2	
P04049	UniProtKB	Metal binding	184	184	.	.	.	Note=Zinc 1	
P04049	UniProtKB	Binding site	375	375	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
P04049	UniProtKB	Modified residue	29	29	.	.	.	Note=Phosphoserine%3B by MAPK1;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q99N57	
P04049	UniProtKB	Modified residue	43	43	.	.	.	Note=Phosphoserine%3B by PKA and MAPK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8349614;Dbxref=PMID:8349614	
P04049	UniProtKB	Modified residue	252	252	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:17525332;Dbxref=PMID:17525332	
P04049	UniProtKB	Modified residue	259	259	.	.	.	Note=Phosphoserine%3B by PKA%2C PKC and PKB/AKT1;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10576742,ECO:0000269|PubMed:10801873,ECO:0000269|PubMed:11756411,ECO:0000269|PubMed:15047712,ECO:0000269|PubMed:16630891,ECO:0000269|PubMed:16892053,ECO:0000269|PubMed:8349614;Dbxref=PMID:10576742,PMID:10801873,PMID:11756411,PMID:15047712,PMID:16630891,PMID:16892053,PMID:8349614	
P04049	UniProtKB	Modified residue	268	268	.	.	.	Note=Phosphothreonine%3B by autocatalysis;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8349614;Dbxref=PMID:8349614	
P04049	UniProtKB	Modified residue	269	269	.	.	.	Note=Phosphothreonine%3B by PKA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7477354;Dbxref=PMID:7477354	
P04049	UniProtKB	Modified residue	289	289	.	.	.	Note=Phosphoserine%3B by MAPK1;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:19690332,ECO:0000269|PubMed:21917714;Dbxref=PMID:19690332,PMID:21917714	
P04049	UniProtKB	Modified residue	296	296	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P04049	UniProtKB	Modified residue	301	301	.	.	.	Note=Phosphoserine%3B by MAPK1;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:21917714;Dbxref=PMID:19690332,PMID:23186163,PMID:21917714	
P04049	UniProtKB	Modified residue	338	338	.	.	.	Note=Phosphoserine%3B by PAK1%2C PAK2%2C PAK3 and PAK5;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11733498,ECO:0000269|PubMed:15849194,ECO:0000269|PubMed:16892053,ECO:0000269|PubMed:18465753,ECO:0000269|PubMed:21917714;Dbxref=PMID:11733498,PMID:15849194,PMID:16892053,PMID:18465753,PMID:21917714	
P04049	UniProtKB	Modified residue	339	339	.	.	.	Note=Phosphoserine%3B by PAK1%2C PAK2 and PAK3;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15849194;Dbxref=PMID:15849194	
P04049	UniProtKB	Modified residue	340	340	.	.	.	Note=Phosphotyrosine%3B by SRC;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16892053;Dbxref=PMID:16892053	
P04049	UniProtKB	Modified residue	341	341	.	.	.	Note=Phosphotyrosine%3B by SRC;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16892053;Dbxref=PMID:16892053	
P04049	UniProtKB	Modified residue	471	471	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16093354;Dbxref=PMID:16093354	
P04049	UniProtKB	Modified residue	491	491	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11447113;Dbxref=PMID:11447113	
P04049	UniProtKB	Modified residue	494	494	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11447113;Dbxref=PMID:11447113	
P04049	UniProtKB	Modified residue	499	499	.	.	.	Note=Phosphoserine%3B by PKC;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8349614;Dbxref=PMID:8349614	
P04049	UniProtKB	Modified residue	563	563	.	.	.	Note=Symmetric dimethylarginine%3B by PRMT5;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21917714;Dbxref=PMID:21917714	
P04049	UniProtKB	Modified residue	621	621	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10801873,ECO:0000269|PubMed:16892053,ECO:0000269|PubMed:21917714,ECO:0000269|PubMed:8349614;Dbxref=PMID:10801873,PMID:16892053,PMID:21917714,PMID:8349614	
P04049	UniProtKB	Modified residue	642	642	.	.	.	Note=Phosphoserine%3B by MAPK1;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
P04049	UniProtKB	Alternative sequence	278	278	.	.	.	ID=VSP_034649;Note=In isoform 2. E->ENNNLSASPRAWSRRFCLRGR;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P04049	UniProtKB	Natural variant	237	237	.	.	.	ID=VAR_071844;Note=In CMD1NN%3B shows a mild increase in kinase activity. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24777450;Dbxref=dbSNP:rs587777588,PMID:24777450	
P04049	UniProtKB	Natural variant	256	256	.	.	.	ID=VAR_037807;Note=In NS5. R->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17603483;Dbxref=dbSNP:rs397516826,PMID:17603483	
P04049	UniProtKB	Natural variant	257	257	.	.	.	ID=VAR_037808;Note=In NS5 and LPRD2%3B shows in vitro greater kinase activity and enhanced ERK activation than wild-type. S->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17603482,ECO:0000269|PubMed:17603483;Dbxref=dbSNP:rs80338796,PMID:17603482,PMID:17603483	
P04049	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_041037;Note=In an ovarian serous carcinoma sample%3B somatic mutation%3B increased ERK activation. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16630891,ECO:0000269|PubMed:17344846;Dbxref=PMID:16630891,PMID:17344846	
P04049	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_037809;Note=In NS5. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17603483;Dbxref=dbSNP:rs397516827,PMID:17603483	
P04049	UniProtKB	Natural variant	260	260	.	.	.	ID=VAR_037810;Note=In hypertrophic cardiomyopathy. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17603483;Dbxref=dbSNP:rs869025501,PMID:17603483	
P04049	UniProtKB	Natural variant	260	260	.	.	.	ID=VAR_037811;Note=In NS5. T->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17603483;Dbxref=PMID:17603483	
P04049	UniProtKB	Natural variant	261	261	.	.	.	ID=VAR_037812;Note=In NS5%3B shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17603482;Dbxref=dbSNP:rs121434594,PMID:17603482	
P04049	UniProtKB	Natural variant	261	261	.	.	.	ID=VAR_037813;Note=In NS5%3B shows greater kinase activity and enhanced MAPK1 activation than wild-type. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17603483;Dbxref=dbSNP:rs397516828,PMID:17603483	
P04049	UniProtKB	Natural variant	261	261	.	.	.	ID=VAR_037814;Note=In NS5%3B shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type. P->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17603482,ECO:0000269|PubMed:17603483,ECO:0000269|PubMed:20683980;Dbxref=dbSNP:rs121434594,PMID:17603482,PMID:17603483,PMID:20683980	
P04049	UniProtKB	Natural variant	263	263	.	.	.	ID=VAR_037815;Note=In NS5%3B shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17603482;Dbxref=dbSNP:rs397516830,PMID:17603482	
P04049	UniProtKB	Natural variant	308	308	.	.	.	ID=VAR_018840;Note=P->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14702039,ECO:0000269|Ref.3;Dbxref=dbSNP:rs5746220,PMID:14702039	
P04049	UniProtKB	Natural variant	310	310	.	.	.	ID=VAR_071845;Note=In CMD1NN%3B shows a mild increase in kinase activity. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24777450;Dbxref=dbSNP:rs778155315,PMID:24777450	
P04049	UniProtKB	Natural variant	332	332	.	.	.	ID=VAR_071846;Note=In CMD1NN%3B shows a mild increase in kinase activity. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24777450;Dbxref=dbSNP:rs1057403865,PMID:24777450	
P04049	UniProtKB	Natural variant	335	335	.	.	.	ID=VAR_041038;Note=In a lung adenocarcinoma sample%3B somatic mutation. Q->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=PMID:17344846	
P04049	UniProtKB	Natural variant	486	486	.	.	.	ID=VAR_037816;Note=In NS5. D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17603483;Dbxref=dbSNP:rs397516815,PMID:17603483	
P04049	UniProtKB	Natural variant	486	486	.	.	.	ID=VAR_037817;Note=In NS5%3B has reduced or absent kinase activity. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17603483;Dbxref=dbSNP:rs80338798,PMID:17603483	
P04049	UniProtKB	Natural variant	491	491	.	.	.	ID=VAR_037818;Note=In NS5%3B has reduced or absent kinase activity. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17603483;Dbxref=dbSNP:rs80338799,PMID:17603483	
P04049	UniProtKB	Natural variant	491	491	.	.	.	ID=VAR_037819;Note=In NS5. T->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17603483;Dbxref=dbSNP:rs80338799,PMID:17603483	
P04049	UniProtKB	Natural variant	603	603	.	.	.	ID=VAR_071847;Note=In CMD1NN%3B shows impaired kinase activity and reduced MAPK3 activation with this mutation. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24777450;Dbxref=dbSNP:rs587777586,PMID:24777450	
P04049	UniProtKB	Natural variant	612	612	.	.	.	ID=VAR_037820;Note=In NS5. S->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17603483;Dbxref=dbSNP:rs1448392469,PMID:17603483	
P04049	UniProtKB	Natural variant	613	613	.	.	.	ID=VAR_037821;Note=In NS5 and LPRD2%3B shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type. L->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17603482,ECO:0000269|PubMed:17603483;Dbxref=dbSNP:rs80338797,PMID:17603482,PMID:17603483	
P04049	UniProtKB	Natural variant	626	626	.	.	.	ID=VAR_071848;Note=In CMD1NN%3B shows a mild increase in kinase activity. H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24777450;Dbxref=PMID:24777450	
P04049	UniProtKB	Natural variant	641	641	.	.	.	ID=VAR_071849;Note=In CMD1NN%3B shows a mild increase in kinase activity. T->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24777450;Dbxref=dbSNP:rs587777587,PMID:24777450	
P04049	UniProtKB	Mutagenesis	338	339	.	.	.	Note=Reduced kinase activity%3B when associated with 340-D-D-341. SS->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16892053;Dbxref=PMID:16892053	
P04049	UniProtKB	Mutagenesis	338	339	.	.	.	Note=Non-inhibited by PPP5C. Constitutively active and non-inhibited by PPP5C%3B when associated with 340-D-D-341. SS->DE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16892053;Dbxref=PMID:16892053	
P04049	UniProtKB	Mutagenesis	340	341	.	.	.	Note=Constitutively active and highly phosphorylated on S-338%2C inhibited by PPP5C. Reduced kinase activity%3B when associated with 338-A-A-339. Constitutively active and non-inhibited by PPP5C%3B when associated with 338-D-E-339. YY->DD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16892053;Dbxref=PMID:16892053	
P04049	UniProtKB	Mutagenesis	491	491	.	.	.	Note=Increased kinase activity but can still be inhibited by PPP5C%3B when associated with D-494. T->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16892053;Dbxref=PMID:16892053	
P04049	UniProtKB	Mutagenesis	494	494	.	.	.	Note=Increased kinase activity but can still be inhibited by PPP5C%3B when associated with D-491. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16892053;Dbxref=PMID:16892053	
P04049	UniProtKB	Mutagenesis	563	563	.	.	.	Note=Loss of methylation. Increased stability and catalytic activity in response to EGF treatment. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21917714;Dbxref=PMID:21917714	
P04049	UniProtKB	Sequence conflict	240	240	.	.	.	Note=F->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P04049	UniProtKB	Sequence conflict	542	542	.	.	.	Note=M->I;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P04049	UniProtKB	Beta strand	57	62	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1C1Y	
P04049	UniProtKB	Turn	63	65	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1C1Y	
P04049	UniProtKB	Beta strand	66	71	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1C1Y	
P04049	UniProtKB	Helix	78	87	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1C1Y	
P04049	UniProtKB	Turn	88	90	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1C1Y	
P04049	UniProtKB	Helix	93	95	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1C1Y	
P04049	UniProtKB	Beta strand	96	102	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1C1Y	
P04049	UniProtKB	Helix	103	105	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1C1Y	
P04049	UniProtKB	Beta strand	106	112	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1C1Y	
P04049	UniProtKB	Helix	118	121	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1C1Y	
P04049	UniProtKB	Beta strand	125	130	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1C1Y	
P04049	UniProtKB	Beta strand	142	144	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FAQ	
P04049	UniProtKB	Beta strand	155	159	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FAQ	
P04049	UniProtKB	Beta strand	161	164	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FAQ	
P04049	UniProtKB	Turn	166	169	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FAQ	
P04049	UniProtKB	Helix	174	176	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FAR	
P04049	UniProtKB	Beta strand	177	182	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FAQ	
